載入...
H(2)Mab-19, an anti-human epidermal growth factor receptor 2 monoclonal antibody exerts antitumor activity in mouse oral cancer xenografts
Human epidermal growth factor receptor 2 (HER2) is reported to be overexpressed in breast cancers and is associated with poor clinical outcome. Trastuzumab is a humanized anti-HER2 antibody that offers significant survival benefits to patients with HER2-overexpressing breast cancer. In this study, a...
Na minha lista:
| 發表在: | Exp Ther Med |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
D.A. Spandidos
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7388441/ https://ncbi.nlm.nih.gov/pubmed/32765652 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2020.8765 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|